HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids.

Abstract
Subcorneal pustular dermatosis (SCPD) is an uncommon disorder, characterized by a chronic relapsing vesiculopustular eruption, mainly involving the trunk and intertriginous areas, and usually seen in women > 40 years old. Various therapies have been reported to be effective in treating SCPD, such as dapsone, systemic glucocorticoids, acitretin, etretinate, infliximab and phototherapy. We report a case of a 54-year-old woman affected by SCPD who after failure of different therapies showed a dramatic but only temporary improvement of her disease during a cycle of therapy with infliximab. In addition, an array of cytokines was simultaneously measured in suction blister fluids obtained from involved or uninvolved skin at various time intervals during the first 12 weeks of observation.
AuthorsC Bonifati, E Trento, P Cordiali Fei, L Muscardin, A Amantea, M Carducci
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 30 Issue 6 Pg. 662-5 (Nov 2005) ISSN: 0307-6938 [Print] England
PMID16197383 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Cytokines
  • Dermatologic Agents
  • Infliximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Blister (metabolism)
  • Body Fluids (metabolism)
  • Cytokines (metabolism)
  • Dermatologic Agents (therapeutic use)
  • Female
  • Humans
  • Infliximab
  • Middle Aged
  • Skin Diseases, Vesiculobullous (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: